Skip to content
Recall Observatory FDA recall evidence

Drug product

fentaNYL 2 mcg/mL + BUPIvacaine 0.125% PF in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0254-40

D-1015-2017

July 14, 2017

Class II

Product summary

Firm
SCA Pharmaceuticals
Event
Event 77770
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-1015-2017

Official wording

Reason: Lack of Assurance of Sterility; product has the potential to leak.

Code information: Lots: 20170503@75 BUD: 8/1/2017; 20170511@21 BUD: 8/9/2017

Distribution pattern: Nationwide

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility